Hyperbaric Oxygen Therapy Combined Camrelizumab in Patients With Advanced/Metastatic Hepatocellular Carcinoma

NCT05031949 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Combinational Immunotherapy
Hepatocellular Carcinoma Non-Resectable
Hyperbaric Oxygen Therapy

Interventions

COMBINATION_PRODUCT: hyperbaric oxygen therapy plus Camrelizumab

Sponsor

Zhang Bi Xiang, MD